Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation.

Journal of hepatology - 1 May 1997

Aye T T, Bartholomeusz A, Shaw T, Bowden S, Breschkin A, McMillan J, Angus P, Locarnini S

Abstract excerpt

BACKGROUND/AIMS: The purpose of this study was to investigate possible resistance mutations which arose in the polymerase gene of hepatitis B virus (HBV) in a patient with severe recurrent HBV infection following liver transplantation. The patient's management included antiviral chemotherapy for almost 4 years comprising ganciclovir, foscarnet and famciclovir. In the last 2.5 years of famciclovir treatment, an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Sequence
Share to Antiviral Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA-Directed DNA Polymerase

Share to Hepatitis B virus

Share to Liver Transplantation

Share to Molecular Sequence Data

Share to Mutation

Source

Identifiers

PMID: 9186847
DOI: 10.1016/s0168-8278(97)80125-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation.PMID 9186847Read ↗

The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss.Semantic proximity Read ↗

Transient selection of a hepatitis B virus polymerase gene mutant associated with a decreased replication capacity and famciclovir resistance.Semantic proximity Read ↗

Clinical experience with famciclovir against hepatitis B virus.Semantic proximity Read ↗

[B domain mutations in the polymerase gene of hepatitis B virus during combination therapy with thymosin alpha1 and famciclovir in Chinese asymptomatic HBV carriers].Semantic proximity Read ↗

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine.Semantic proximity Read ↗

Mutations in the hepatitis B virus polymerase gene associated with antiviral treatment for hepatitis B.Semantic proximity Read ↗

Hepatitis B virus mutations potentially conferring adefovir/tenofovir resistance in treatment-naive patients.Semantic proximity Read ↗

Serum hepatitis B virus RNA levels as an early predictor of hepatitis B envelope antigen seroconversion during treatment with polymerase inhibitorsSemantic proximity Read ↗

Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir.Semantic proximity Read ↗

Characterization of hepatitis B virus surface antigen and polymerase mutations in liver transplant recipients pre- and post-transplant.Semantic proximity Read ↗

Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations.Semantic proximity Read ↗

Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.